EVH Evolent Health Inc

Price (delayed)

$19.11

Market cap

$1.65B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.94

Enterprise value

$1.66B

Sector: Healthcare
Industry: Health Information Services

Highlights

The revenue has grown by 21% YoY and by 3.6% from the previous quarter
EVH's gross profit is up by 18% year-on-year and by 8% since the previous quarter
The EPS rose by 36% QoQ but it fell by 7% YoY
Evolent Health's net income has increased by 35% QoQ but it has decreased by 11% YoY
The company's equity fell by 33% YoY

Key stats

What are the main financial stats of EVH
Market
Shares outstanding
86.09M
Market cap
$1.65B
Enterprise value
$1.66B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.65
Price to sales (P/S)
1.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.63
Earnings
Revenue
$1.02B
EBIT
-$309.46M
EBITDA
-$247.99M
Free cash flow
-$45.7M
Per share
EPS
-$3.94
Free cash flow per share
-$0.54
Book value per share
$7.22
Revenue per share
$12.04
TBVPS
$8.8
Balance sheet
Total assets
$1.37B
Total liabilities
$750.59M
Debt
$359.78M
Equity
$619.6M
Working capital
$144.36M
Liquidity
Debt to equity
0.58
Current ratio
1.36
Quick ratio
1.21
Net debt/EBITDA
-0.08
Margins
EBITDA margin
-24.3%
Gross margin
22.8%
Net margin
-32.7%
Operating margin
-26.5%
Efficiency
Return on assets
-24.4%
Return on equity
-48.7%
Return on invested capital
-60.1%
Return on capital employed
-32%
Return on sales
-30.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
4.26%
1 week
-5.16%
1 month
-0.98%
1 year
125.89%
YTD
19.21%
QTD
19.21%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$1.02B
Gross profit
$233.11M
Operating income
-$270.62M
Net income
-$334.25M
Gross margin
22.8%
Net margin
-32.7%
The operating margin has increased by 46% from the previous quarter and by 27% YoY
The company's operating income rose by 44% QoQ and by 12% YoY
The net margin has increased by 38% QoQ and by 8% YoY
Evolent Health's net income has increased by 35% QoQ but it has decreased by 11% YoY

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
2.65
P/S
1.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.63
The EPS rose by 36% QoQ but it fell by 7% YoY
EVH's price to book (P/B) is 104% higher than its last 4 quarters average of 1.3 and 89% higher than its 5-year quarterly average of 1.4
The company's equity fell by 33% YoY
The price to sales (P/S) is 77% higher than the last 4 quarters average of 0.9 but 34% lower than the 5-year quarterly average of 2.4
The revenue has grown by 21% YoY and by 3.6% from the previous quarter

Efficiency

How efficient is Evolent Health business performance
The ROE has plunged by 72% YoY but it has grown by 28% from the previous quarter
The ROS rose by 42% QoQ and by 17% YoY
Evolent Health's return on assets has increased by 34% QoQ but it has decreased by 31% YoY
EVH's return on invested capital is up by 31% since the previous quarter but it is down by 13% year-on-year

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 83% higher than its total liabilities
The quick ratio has grown by 17% YoY but it has contracted by 10% from the previous quarter
The company's current ratio rose by 14% YoY but it fell by 9% QoQ
The debt is 42% lower than the equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.